Literature DB >> 17713773

Diagnostic and therapeutic problems of giant cell tumor in the proximal femur.

Kenshi Sakayama1, Yoshifumi Sugawara, Teruki Kidani, Joji Miyawaki, Taketsugu Fujibuchi, Setsuya Kamei, Junichi Aizawa, Haruyasu Yamamoto.   

Abstract

Primaly giant cell tumor of bone (GCT) in the proximal femur is relatively rare, and can prove difficult to diagnose, and can require therapeutic methods. Subjects comprised 10 patients (8 males, 2 females). Mean patient age was 27.5 years, and mean follow-up was 89.9 months. Tumors in the present study were limited to H1 and H2 according to the International Society of Limb Salvage (ISOLS) system. All patients received surgical treatment only. Second surgery after preoperative open biopsy was performed for two patients, while the remaining eight patients received excisional biopsy to determine treatment methods using rapid intraoperative pathological examination of frozen sections. The mean functional score was 28.2 out of 30 (93.9%). Local recurrence was observed in two patients. The long-term follow-up reveals that one of the important problem is pre-operative diagnosis. Excisional biopsy is effective for surgery of GCT in the proximal femur.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17713773     DOI: 10.1007/s00402-007-0419-3

Source DB:  PubMed          Journal:  Arch Orthop Trauma Surg        ISSN: 0936-8051            Impact factor:   3.067


  10 in total

Review 1.  Prognosis of local recurrence in giant cell tumour of bone: what can we do?

Authors:  Yifeng He; Ji Zhang; Xiaoyi Ding
Journal:  Radiol Med       Date:  2017-03-07       Impact factor: 3.469

2.  Surgical strategy for benign lesions in proximal femur: internal fixation or endoprosthetic replacement.

Authors:  Hongyuan Liu; Xiang Fang; Zeping Yu; Yun Lang; Yan Xiong; Hong Duan
Journal:  Int Orthop       Date:  2018-04-17       Impact factor: 3.075

3.  Higher local recurrence rates after intralesional surgery for giant cell tumor of the proximal femur compared to other sites.

Authors:  Costantino Errani; Shinji Tsukamoto; Giulio Leone; Manabu Akahane; Luca Cevolani; Piergiuseppe Tanzi; Akira Kido; Kanya Honoki; Yasuhito Tanaka; Davide Maria Donati
Journal:  Eur J Orthop Surg Traumatol       Date:  2017-06-06

4.  Long-term outcomes of ultrasonic scalpel treatment in giant cell tumor of long bones.

Authors:  Sheng Sun; Qiang Zhang; Chang-Song Zhao; Juan Cai
Journal:  Oncol Lett       Date:  2014-04-25       Impact factor: 2.967

5.  Local control of giant cell tumors of the long bone after aggressive curettage with and without bone cement.

Authors:  Zhen-hua Gao; Jun-qiang Yin; Xian-biao Xie; Chang-ye Zou; Gang Huang; Jin Wang; Jing-nan Shen
Journal:  BMC Musculoskelet Disord       Date:  2014-10-02       Impact factor: 2.362

6.  The dilemma of denosumab: Salvage of a femoral head giant cell tumour.

Authors:  Czar Louie Gaston; Florian Puls; Robert John Grimer
Journal:  Int J Surg Case Rep       Date:  2014-09-22

7.  A single-component and hemi-hip prosthesis followed up for 43 years: A case report.

Authors:  Yuan Liu; Hang-Jun Chen; Bin Zhang; Xu-Qiang Liu; Jun Xiao; Cheng-Kung Cheng; Min Dai
Journal:  Medicine (Baltimore)       Date:  2019-02       Impact factor: 1.889

8.  Comparative Analysis of Two Surgical Treatment Options for Giant Cell Tumor of the Proximal Femur: Extended Curettage and Segmental Resection.

Authors:  Yuhao Yuan; Qing Liu; Yupeng Liu; Ziyi Wu; Wei Zhong; Hongbo He; Wei Luo
Journal:  Front Oncol       Date:  2021-12-20       Impact factor: 6.244

9.  Giant Cell Tumor of the Femoral Head: A Case Report and Review of the Literature.

Authors:  Hany Elbardesy; G A Sheridan; S Guerin
Journal:  J Orthop Case Rep       Date:  2021-05

10.  Surgical treatment of benign osteolytic lesions in the femoral head and neck: a systematic review.

Authors:  Jingtian Shi; Zhiqing Zhao; Taiqiang Yan; Wei Guo; Rongli Yang; Xiaodong Tang; Huayi Qu; Sen Dong
Journal:  BMC Musculoskelet Disord       Date:  2021-06-16       Impact factor: 2.362

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.